The European landscape is witnessing a fascinating evolution in the perception of psychedelics. Recently stigmatized, these substances have begun to gain traction for their potential therapeutic applications. From Germany, where clinical trials are in progress, to the France, where open conversations is growing, Europe stands out in this resurgence